CIDRAP newsletters options
In 2023 the outbreaks were linked to 12 deaths.
An investigation is under way into exactly where the patient contracted the infection.
The preventive drug was 84% effective in preventing RSV-associated hospital care.
A further 5% drop in coverage could substantially increase outbreak magnitudes in Texas, while restricting non–medical exemptions could increase US uptake.
Officials in the Americas have reported 11,313 cases so far this year.
The 8-month-old cow had recently been moved to a certified feedlot in Nuevo Leon from a southern Mexico area with active infections.
In 2021, China accounted for 14% of global deaths attributable to AMR and 15% of deaths associated with AMR.
ACIP narrowly rejects its working group’s proposal to require a doctor’s prescription for the vaccine.
Regarding information from the CDC, 64% of Americans expressed confidence, compared with 63% for the FDA and 62% for the NIH.
In another vote, ACIP reversed itself and removed the MMRV vaccine from the Vaccines for Children program.
Seven states and New York City have been collaborating since early 2025 but formally announced the collaborative yesterday.
Among more than 10,000 participants with prior infection, the odds of having long COVID symptoms were lower in those aged 70 and older than in younger age-groups.
Of 37 countries with national action plans, only 3 saw significant reductions in antibiotic sales.
The committee removes a long-standing ACIP recommendation that said parents may choose the MMRV vaccine for kids 12 to 47 months old.
COVID-19 patients with cardiovascular symptoms, especially those with prior heart disease, should begin an exercise rehabilitation program 6 to 12 weeks after infection, the authors say.
The study is timely, because tomorrow the CDC's vaccine advisory committee will discuss COVID vaccines and could further restrict their use.
The USDA also reports an H5 avian flu detection in a raccoon in Minnesota.
Canada's priority pathogens list shows that 45% of the assessed AMR pathogens disproportionately affect marginalized populations and those with structural barriers to health.
One child with an unknown exposure and 3 adults with a history of consuming raw palm sap, a known risk factor, died of unrelated infections.
Treatment capacity is rising, and 14 people have been treated with the MAb114 monoclonal antibody.
